BioStock: Neola’s CEO: “The doors open for us in the US”

Lund-based Neola Medical released its report for the third quarter last week. The company’s efforts to establish itself on the US market have begun to bear fruit and they have also presented promising clinical data that further strengthens their lung monitoring system Neola. BioStock has reached out to CEO Hanna Sjöström to get her thoughts on the past quarter and to find out what happens next.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/11/neolas-ceo-the-doors-open-for-us-in-the-us/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se